Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Erfurt – page 16

447 clinical trials in Erfurt, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Erfurt at a glance
447
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

447 trials in Erfurt

Open in trial search

Crohn's disease

Recruiting

Study on INTESTIFIX for Maintaining Remission in Children and Adults with Crohn's Disease After Exclusive Enteral Nutrition Treatment

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Intestifix
  • Sponsor:Klinikum Der Universitat Munchen AöR

Study on the Effect of Rifampicin and Drug Combination for Patients with Staphylococcus aureus Bacteremia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Universitair Medisch Centrum Utrecht

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Celgene Corp.

Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Triple Negative Breast Cancer with Residual Disease After Surgery and Therapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Gilead Sciences Inc.

Ocular myasthenia

Not yet recruiting

Phase 3 Open‑Label Extension Study of Long‑Term Safety and Efficacy of Rozanolixizumab in Adults with Ocular Myasthenia Gravis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma

A study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Usnoflast
  • Sponsor:Zydus Therapeutics Inc.

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Carcinoid syndrome

Not yet recruiting

Efficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Paltusotine
  • Sponsor:Crinetics Pharmaceuticals Inc.

Conjunctivitis allergic

Not yet recruiting

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Malignant peritoneal neoplasm+1

Not yet recruiting

Maintenance therapy with raludotatug deruxtecan alone or with bevacizumab versus standard care in patients with newly diagnosed advanced ovarian cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Cilcare

Endometrial cancer

Not yet recruiting

Maintenance Treatment Study of gsk5733584 with dostarlimab or pembrolizumab in patients with mismatch repair proficient advanced or recurrent endometrial cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Erfurt

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on various cancer types including non-small cell lung cancer, breast cancer, and melanoma. Research evaluates innovative treatment combinations and immunotherapy approaches.

  • Advanced treatment strategies for lung cancer patients
  • Targeted therapies for HER2-positive breast cancer
  • Novel melanoma treatment combinations

Multiple trials investigating combination therapies and immunological approaches for improved patient outcomes.

02 Cardiovascular Studies

Innovative research targeting atherosclerotic cardiovascular disease and hypercholesterolemia. Studies focus on new therapeutic approaches for managing cholesterol levels and reducing cardiovascular risks.

  • Cholesterol management therapies
  • Blood pressure control studies
  • Cardiovascular risk reduction

Trials evaluating novel medications for better management of cardiovascular conditions.

03 Hematology Research

Comprehensive studies on blood-related conditions including acute lymphoblastic leukemia and multiple myeloma. Focus on developing effective treatments for both pediatric and adult patients.

  • Leukemia treatment protocols
  • Multiple myeloma therapies
  • Lymphoma treatment strategies

Advanced treatment protocols combining established and innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.